Mycobacterium leprae: Difference between revisions

From IDWiki
Mycobacterium leprae
No edit summary
(added background section)
Line 1: Line 1:
== Background ==
=== Microbiology ===
* Slow-growing [[Has Gram stain::acid-fast]] [[Has shape::bacillus]]

=== Epidemiology ===
* About 1 million cases worldwide each year, but is rare in North America
** Number may be underestimated due to difficulties with reliable diagnosis
* Most commonly occurs in Southeast Asia (especially India) and Brazil
* Decreasing incidence over the past several decades, likely due to short-course multidrug therapy starting in 1982
* Humans are thought to be the main reservoir, but it has been found in animals as well (particularly armadillos)
* Transmitted most likely by respiratory droplets, though can also be transmitted by direct contact, transplacentally, through breast milk, and after animal exposure

=== Risk Factors ===
* Age, with peaks in adolescence and ≥30 years
* Adult men (compared to adult women)
* Duration of contact with an infected patient, and the burden of bacilli in the patient

=== Pathophysiology ===


== Clinical Presentation ==
== Clinical Presentation ==

Revision as of 13:31, 27 November 2019

Background

Microbiology

Epidemiology

  • About 1 million cases worldwide each year, but is rare in North America
    • Number may be underestimated due to difficulties with reliable diagnosis
  • Most commonly occurs in Southeast Asia (especially India) and Brazil
  • Decreasing incidence over the past several decades, likely due to short-course multidrug therapy starting in 1982
  • Humans are thought to be the main reservoir, but it has been found in animals as well (particularly armadillos)
  • Transmitted most likely by respiratory droplets, though can also be transmitted by direct contact, transplacentally, through breast milk, and after animal exposure

Risk Factors

  • Age, with peaks in adolescence and ≥30 years
  • Adult men (compared to adult women)
  • Duration of contact with an infected patient, and the burden of bacilli in the patient

Pathophysiology

Clinical Presentation

  • Incubation period of 3-5 years (with wide range)
  • Classic presentation is anaesthetic hypopigmented skin lesion with thickened nerves
  • Clinical spectrum from tuberculoid, paucibacillary disease to lepromatous, multibacillary disease
    • Paucibacillary (PB) disease has 1 to 5 skin lesions, without bacilli on skin slit smear
    • Multibacillary (MB) disease has more than 5 skin lesions, with or without nerve involvement or bacilli on slit-skin smear (regardless of number of lesions)

Management

Disease Treatment
Paucibacillary 6 months of rifampin, dapsone, and clofazimine
Multibacillary 12 months of rifampin, dapsone, and clofazimine
Rifampin resistance 6 months of at least two second-line drugs with clofazimine, followed by 18 months of one second-line drug with clofazimine
Quinolone resistance As for rifampin resistance, but without a fluoroquinolone

Second-line antibiotics